Putting the IMPACT Study into Perspective: Should CMV Prophylaxis Be Extended to 6 Months for High Risk Transplants?

摘要

The author critically assesses the debate over the proper interpretation of the IMPACT trial regarding CMV prophylaxis in high risk recipients, and whether one should extend prophylaxis for 6 months. See viewpoint by Kalil et al on page 18 and letter by Humar on page 177.